P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL-LIFE DATA FROM VERONE STUDY
Loïc Ysebaert,
Xavier Troussard,
Vincent Levy,
Ronan Le Calloch,
Romain Guieze,
Kamel Laribi,
Stephane Lepretre,
Anne Sophie Michallet,
Véronique Leblond,
Pierre Feugier,
Elhem Lahjibi,
Julien Ramier,
Alain Delmer
Affiliations
Loïc Ysebaert
1 IUCT Oncopole, Hematology, Toulouse, France
Xavier Troussard
2 Caen University Hospital, Hematology, Caen, France
Vincent Levy
3 Avicenne Hospital, Hematology, Bobigny, France
Ronan Le Calloch
4 Hospital Center, Quimper, Hematology, Quimper, France
Romain Guieze
5 Estaing University Hospital, Hematology, Clermont-Ferrand, France
Kamel Laribi
6 Le Mans Hospital Center, Hematology, Le Mans, France
Stephane Lepretre
7 Henri Becquerel Center, Hematology, Rouen, France
Anne Sophie Michallet
8 Cancer Research Center Lyon, Hematology, Lyon, France
Véronique Leblond
9 Pitié-Salpêtrière University Hospital, Hematology, Paris, France
Pierre Feugier
10 Nancy University Hospital, Hematology, Vandœuvre-lès-Nancy, France
Elhem Lahjibi
11 AbbVie, Medical Affairs, Rungis, France
Julien Ramier
11 AbbVie, Medical Affairs, Rungis, France
Alain Delmer
12 Reims University Hospital, Hematology, Reims, France
